A national programme of bivalent prefusion F vaccination in pregnancy and protection against respiratory syncytial virus hospitalisation in infants until age 6 months in the UK: a multicentre, prospective, test-negative, case–control study
The Lancet Child & Adolescent Health
•
July 03, 2026
Maternal RSV vaccination reduced infant hospitalizations
Maternal respiratory syncytial virus vaccination reduced infant hospital admission through 6 months. *Prospective test-negative case-control study; Level 3 (OCEBM).
- Level of evidence
- Level 3 (OCEBM)
- DocG quality score
- 7.2 / 10
Read the full summary free
Patients, intervention, outcomes, results, and clinical applicability in about 300 words — plus new summaries in your inbox 3× per week.
Sign in with Google
